Krams on Popularizing the Adaptive Approach
November 21, 2012 | Adaptive clinical trials might be globally embraced if the current preoccupation with fixed trial designs was viewed as an “engineering problem” requiring a lot of talk and teamwork between adaptive design experts, said Michael Krams, MD, vice president & head of the neurology franchise at Johnson & Johnson (J&J). Bio-IT World
Click here to log in.
Text Only 2000 character limit
Page 1 of 1